Image For Activity Cover
JAAD 03/23 Risk of melanoma and nonmelanoma skin cancer with immunosuppressants. Part II: Methotrexate, alkylating agents, biologics, and small molecule inhibitors
Availability: On-Demand
Expires on Mar 31, 2026
Credit Offered:
1 CME Credit
4 MOC-PART2 Points

Legal notice
Copyright © 2022 American Academy of Dermatology. All rights reserved.
Reproduction or republication strictly prohibited without prior written permission.
Powered By